AstraZeneca, Daiichi Drug Approved as New First-Line Therapy for Tough Type of Breast CancerNews DeskMay 25, 20260 A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast…